Amylyx Pharmaceuticals, Inc. (AMLX) Gross profit 2022–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual gross profit history from SEC filings — each fiscal year as reported.
$0FY2025 · since FY2022: $19.2M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $81.4M | -77.1% |
| FY2023 | $355.3M | +1747.2% |
| FY2022 | $19.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMLX financial trends
AMLX RevenueAMLX Net incomeAMLX Net marginAMLX Gross marginAMLX Operating incomeAMLX Operating marginAMLX Operating cash flowAMLX Free cash flowAMLX Capital expendituresAMLX Return on equityAMLX Stock buybacksAMLX Dividends paidAMLX Total assetsAMLX Total liabilitiesAMLX Shareholders’ equityAMLX overview →